AI

Move over, cartography – this is heartography

A new, highly-detailed cellular and molecular map of the human heart could guide personalised treatments. A research team has produced a detailed map of a...

Big pharma enters senolytic drug discovery programme

Japanese pharma Taisho teams with Insilico to discover novel molecules that will tackle aging. It was announced today that Taisho Pharmaceutical and Insilico Medicine have...

Longevity in the workplace

iamYiam’s SYD platform aims to improve employee life quality with AI. With over half our lives spent at work, it’s no surprise that our workplace...

Using small data to target Alzheimer’s

NetraMark CEO on using AI to identify novel targets for treatment of Alzheimer’s disease. Despite the billions spent on research and development into treatments for...

Jinfiniti’s Startup Showcase success drives collaboration

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases. Augusta University spin-out Jinfiniti was our first Startup Showcase, and they...

Bucket list: AI models predict how much time is left

New study uses machine learning models for biological life prediction - with good accuracy. Age is just a piece of paper – chronological age, that...

Tina Woods: Prevention is vital for Longevity

Longevity International’s Tina Woods tells us how the Longevity industry is releasing us from being trapped in the cycle of ill health and chronic...

Exclusive video interview with Dave Asprey

We talk supplementation, neurotech, mitochondrial dysfunction, clinical scale-ups, COVID and CGM with Longevity legend: Dave Asprey Ahead of Revolution Against Aging and Death conference, which...

Making tracks for Longevity – tackling the dementia challenge

Music to your ears - our interview with Memory Tracks CEO Gordon Anderson. The threat of neurodegenerative disease looms over the benefits of extended life....

AI diagnoses osteoarthritis 3 years-out from symptoms

New AI diagnostic technique could diagnose osteoarthritis three years before symptoms – paving the way for preventative therapies.  One of the worst things about getting...

Longevity 1.0 – new book seeks to define Longevity

"Global finance has reached a crossroads where it must decide how to approach the issue of a global aging population – either as a...

Insilico opens Pandomics box for AI target discovery

Insilico announces Pandomics, an AI-powered hypothesis generation engine that interprets OMICS and text-based data for the discovery and analysis of new therapeutic targets. Insilico is...

AI app reveals your biological age – and how to slow it down

Only as old as you feel ... or only as old as your Young.AI app tells you? We use our phones for just about everything...

When AI means artificial immortality: just ask Alexa

Hereafter is turning dead ends into conversational opportunities. Understandably, we use Longevity in a mostly physical sense - extending lifespan and healthspan and combating aging...

New immune aging drug brings Longevity and C19 hope

Phase 2-ready drug can treat and reverse immune aging, BioAge claims. BioAge Labs' in-licensed clinical-stage therapy has potential for treating immune aging in older patients...

Epigenetic reprogramming: the road to reversing time

Epigenetic modifications – also known as “aging clocks” – have emerged as promising markers of aging and accurate predictors of age-related diseases; they're a hot...

Insilico teams-up with Intel to identify disease progression risk

Insilico's new COVIDomic platform combines cutting-edge AI with Intel Xeon processors and could turn the pandemic tide. Insilico have been rather busy lately; a couple...

Biofourmis raises $100M to scale digital therapeutics

Health start-up Biofourmis, which leverages AI for personalised healthcare monitoring, has raised $100m from SoftBank. SoftBank Group has led a $100m investment in Biofourmis, the...

Deep Longevity acquired by Regent Pacific

Hong Kong public company enters Longevity business by acquiring aging clock specialist Deep Longevity. Not even two months after it exited stealth to announce its...

Relation-Mila collaboration wins $1.3m Gates Foundation Award to fight COVID-19

Relation receives $1.3m grant funding from the Gates Foundation to identify COVID-19 therapeutic candidates. Relation Therapeutics (a Juvenescence-incubated company) and Mila, the Montreal-based AI research...

Latest articles

Peptide molecule causes cancer cells to self destruct

New breakthrough by a team led by eminent oncologist Loren Walensky brings new hope for future cancer treatments – and Longevity.  Everyone needs a way...

WHO portal brings aging data together

We live in a world driven by data and the World Health Organization (WHO) has now launched the first data portal to bring together...

The natural medicine war chest to fight aging

Quicksilver's liposomal delivery system boasts a non-invasion of the body patchers. Colorado-based Quicksilver Scientific manufactures a range of supplements from immunity boosters to NAD+. By...

Jim Mellon and Phil Newman: Longevity interviews

Master Investor is a publication that helps private investors to take charge of their financial destiny: covering a range of subjects, from shares to...